Specialty
Aparato digestivo
Publications (38) Publications in which a researcher has participated
2024
-
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels
Clinical Gastroenterology and Hepatology
-
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death
Scientific reports, Vol. 14, Núm. 1, pp. 3000
-
A heart-stopping procedure: severe esophageal injury arising from difficulty in withdrawal of a motorized spiral enteroscope
Endoscopy, Vol. 56, Núm. S 01, pp. E476-E477
-
An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresis
Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 347-351
-
Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopy
Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 246-252
-
CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions
Gastric Cancer, Vol. 27, Núm. 4, pp. 747-759
-
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Therapeutic Advances in Gastroenterology, Vol. 17
-
Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study
Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 727-733
-
Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study
Gastroenterologia y Hepatologia
-
Editorial: Mucosal healing with steroids: Once upon a time in ulcerative colitis
Alimentary Pharmacology and Therapeutics
-
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259
-
Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance
American Journal of Gastroenterology, Vol. 119, Núm. 4, pp. 646-654
-
Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta-analysis of randomized controlled trials
United European Gastroenterology Journal
-
Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy
International Journal of Cancer, Vol. 154, Núm. 1, pp. 124-132
-
Environmental Exposure to Trace Elements and Heavy Metals Preceding the Clinical Onset of Inflammatory Bowel Disease
Crohn's and Colitis 360, Vol. 6, Núm. 1
-
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264
-
Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
Gut Microbes, Vol. 16, Núm. 1
-
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
Journal of Crohn's and Colitis, Vol. 18, Núm. 3, pp. 349-359
-
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)
Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 750-758
-
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)
Helicobacter, Vol. 29, Núm. 4